799268-03-4

Basic information

• Product Name: Carbamic acid, [(1S,2E)-1-[(4S,5R)-2,2-dimethyl-5-tetradecyl-1,3-dioxolan-4-yl]-3-[(2R, 3S,4R,5S,6R)-tetrahydro-3,4,5-tris(phenylmethoxy)-6-[(phenylmethoxy) methyl]-2H-pyran-2-yl]-2-propenyl]-, 1,1-dimethylethyl ester
• CAS NO: 799268-03-4
• Molecular Formula: C61H85NO9
• Molecular Weight: 976.347
• Mol File: 799268-03-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S,2E)-1-[(4S,5R)-2,2-dimethyl-5-tetradecyl-1,3-dioxolan-4-yl]-3-[(2R, 3S,4R,5S,6R)-tetrahydro-3,4,5-tris(phenylmethoxy)-6-[(phenylmethoxy) methyl]-2H-pyran-2-yl]-2-propenyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S,2E)-1-[(4S,5R)-2,2-dimethyl-5-tetradecyl-1,3-dioxolan-4-yl]-3-[(2R, 3S,4R,5S,6R)-tetrahydro-3,4,5-tris(phenylmethoxy)-6-[(phenylmethoxy) methyl]-2H-pyran-2-yl]-2-propenyl]-, 1,1-dimethylethyl ester(799268-03-4)
• EPA Substance Registry System: Carbamic acid, [(1S,2E)-1-[(4S,5R)-2,2-dimethyl-5-tetradecyl-1,3-dioxolan-4-yl]-3-[(2R, 3S,4R,5S,6R)-tetrahydro-3,4,5-tris(phenylmethoxy)-6-[(phenylmethoxy) methyl]-2H-pyran-2-yl]-2-propenyl]-, 1,1-dimethylethyl ester(799268-03-4)

Safety Data

• Hazardous Substances Data: 799268-03-4(Hazardous Substances Data)

Upstream product

• 856668-29-6 1,3,4,5-tetra-O-acetyl-2,6-anhydro-7,8,9-trideoxy-D-glycero-L-galacto-non-7-enitol 
• 287962-77-0 (2R,3S,4R,5S,6R)-3,4,5-tribenzyloxy-2-(benzyloxymethyl)-6-ethynyl-tetrahydropyran 
• 554-62-1 D-ribo-phytosphingosine 
• 60933-76-8 Acetic acid (2R,3S,4R,5S,6R)-3,5-diacetoxy-2-acetoxymethyl-6-vinyl-tetrahydro-pyran-4-yl ester 
• 799267-96-2 [(S)-1-((4S,5R)-2,2-Dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-allyl]-carbamic acid tert-butyl ester 
• 799267-94-0 2,3,4,6-tetra-O-benzyl-1-deoxy-α-D-galactopyranosylethene 
• 799267-93-9 trans-2,3,4,6-tetra-O-benzyl-1-deoxy-1-(prop-1'-enyl)-α-D-galactopyranose 
• 799267-98-4 1-N-tert-butyloxycarbonyl-3,4-O-isopropylidene-phytosphingosine 
• 799268-00-1 2-[N-(tert-butoxycarbonyl)amino]-3,4-O-isopropylideneoctadecan-1-al 
• 181824-87-3 [(S)-2-(tert-Butyl-dimethyl-silanyloxy)-1-((4S,5R)-2,2-dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-ethyl]-carbamic acid tert-butyl ester 
• 175696-50-1 tert-butyl [(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]carbamate 
• 799267-97-3 [1-(tert-butyl-dimethyl-silanyloxymethyl)-2,3-dihydroxy-heptadecyl]-carbamic acid tert-butyl ester 

Downstream Products

• 865880-62-2 C₇₉H₁₂₃NO₈ 
• 865880-64-4 C₈₀H₁₂₃NO₈ 

Relevant articles and documents

Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases

The invention is directed to novel compounds of formulae (I), (II) and (III): wherein X is O or NH; R3 is OH or a monosaccharide and R4 is hydrogen, or R3 is hydrogen and R4 is OH or a monosaccharide; R5 is hydrogen or a monosaccharide; and pharmaceutically acceptable salts or esters thereof. The invention is also directed to the use of the compounds both directly and as immune adjuvants for treating cancer, infectious diseases and autoimmune diseases. The invention is also directed to syntheses of the intermediates which can be used to make these novel compounds.